Vladimir N Ivanov Selected Research

Glioblastoma (Glioblastoma Multiforme)

9/2021	Author Correction: Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures.
1/2020	Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures.
12/2019	Correction: Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells.
1/2019	Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells.
9/2017	Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-radiation and small molecule inhibitors of cell signaling pathways.
12/2014	Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir N Ivanov Research Topics

Disease

16	Melanoma (Melanoma, Malignant) 07/2015 - 05/2003
12	Neoplasms (Cancer) 01/2019 - 02/2002
6	Glioblastoma (Glioblastoma Multiforme) 09/2021 - 12/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2016 - 07/2015
2	Brain Neoplasms (Brain Tumor) 12/2014 - 03/2014
2	Skin Neoplasms (Skin Cancer) 06/2007 - 01/2006
1	Wounds and Injuries (Trauma) 07/2015
1	Pathologic Processes 07/2015
1	Liver Neoplasms (Liver Cancer) 04/2013
1	Neuroblastoma 12/2011
1	Genomic Instability 06/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2009
1	Acute Promyelocytic Leukemia 12/2006
1	Leukemia 05/2004
1	Neoplasm Metastasis (Metastasis) 05/2003

Drug/Important Bio-Agent (IBA)

9	sodium arsenite (sodium metaarsenite)IBA 07/2015 - 05/2006
7	NF-kappa B (NF-kB)IBA 04/2009 - 05/2003
6	arseniteIBA 03/2008 - 05/2004
5	CannabidiolIBA 09/2021 - 09/2017
5	Phosphotransferases (Kinase)IBA 12/2019 - 06/2003
4	Death Domain ReceptorsIBA 07/2015 - 05/2003
4	Transcription Factors (Transcription Factor)IBA 02/2013 - 05/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 05/2004
4	Fas Ligand Protein (Fas Ligand)IBA 06/2007 - 05/2003
3	ArsenicIBA 09/2016 - 05/2004
3	Proteins (Proteins, Gene)FDA Link 12/2011 - 03/2008
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2009 - 05/2003
3	LigandsIBA 04/2009 - 01/2005
2	Thymidine Monophosphate (TMP)IBA 09/2016 - 07/2015
2	CytokinesIBA 07/2015 - 02/2011
2	Insulin (Novolin)FDA Link 07/2015 - 07/2010
2	Interleukin-8 (Interleukin 8)IBA 12/2014 - 02/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2014 - 02/2011
2	Drinking WaterIBA 04/2013 - 02/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2011 - 02/2011
2	TNF-Related Apoptosis-Inducing LigandIBA 07/2010 - 01/2005
2	ResveratrolIBA 06/2008 - 03/2008
2	fas Receptor (CD95 Antigen)IBA 05/2006 - 02/2002
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2005 - 05/2004
1	zinc protoporphyrinIBA 09/2016
1	AntioxidantsIBA 07/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 07/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Serum-Free Culture MediaIBA 07/2015
1	tetramethylpyrazineIBA 07/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015
1	Glutathione (Reduced Glutathione)IBA 07/2015
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 07/2015
1	NestinIBA 07/2015
1	Lovastatin (Mevacor)FDA LinkGeneric 12/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2011
1	Simvastatin (Zocor)FDA LinkGeneric 12/2011
1	Heme Oxygenase-1IBA 12/2011
1	Caspase 8 (Caspase-8)IBA 12/2011
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	Monoclonal AntibodiesIBA 02/2011
1	Growth Factor ReceptorsIBA 07/2010
1	Ataxia Telangiectasia Mutated ProteinsIBA 04/2009
1	Small Interfering RNA (siRNA)IBA 04/2009
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 04/2009
1	Pharmaceutical PreparationsIBA 12/2006
1	Apoptosis Regulatory ProteinsIBA 12/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2006
1	Dynamins (Dynamin)IBA 01/2006
1	Mitogen-Activated Protein KinasesIBA 01/2005
1	Transforming Growth Factor alpha (TGF-alpha)IBA 01/2005
1	ErbB Receptors (EGF Receptor)IBA 01/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2005
1	CarcinogensIBA 05/2004
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2004
1	GTP-Binding Proteins (G-Protein)IBA 05/2003
1	Protein Kinases (Protein Kinase)IBA 05/2003
1	Amino Acids FDA Link 05/2003

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
5	Therapeutics 01/2019 - 05/2003
1	Radiotherapy 01/2020
1	Cranial Irradiation 03/2014